Skip to content

Time-course of Mitochondrial Biogenic Gene and Protein Expression in Exercised Human Skeletal Muscle

Impact of Exercise Intensity on the Time-course of Mitochondrial Biogenic Gene and Protein Expression in Human Skeletal Muscle.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03975777
Enrollment
10
Registered
2019-06-05
Start date
2019-06-01
Completion date
2020-04-30
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitochondrial Biogenesis

Brief summary

This study examines the impact of exercise intensity on the 12-hour time-course of mitochondrial biogenic gene and protein expression in human skeletal muscle. Briefly, participants will perform two experimental sessions involving an acute bout of work-matched low- or high-intensity interval cycling exercise in a randomized crossover fashion, two weeks apart. Skeletal muscle biopsies will be obtained from the vastus lateralis (3 from each leg) before and 1, 3, 6, 9, and 12 hours post-exercise. Changes in the expression of various transcription factors and mitochondrial proteins will be examined at the mRNA and protein level to determine the time-course of changes in these factors differs between exercise protocols of different intensities.

Interventions

OTHERLO

Participants will perform an acute bout of low-intensity cycling (11 x 1 min intervals at \ 73% of peak aerobic work rate interspersed with 1 min recovery periods)

OTHERHI

Participants will perform an acute bout of high-intensity cycling (8 x 1 min intervals at \ 100% of peak aerobic work rate interspersed with 1 min recovery periods)

Sponsors

Brendon Gurd, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* recreationally active (no more than three hours of structured weekly physical activity) * not currently involved in a systematic training program for improving cardiorespiratory fitness, muscular strength, and/or sport-specific skills * body mass index \< 30 kg/m2

Exclusion criteria

* presence of cardiometabolic disease * taking regular prescription medication for the treatment of cardiometabolic disease * current cigarette smoker

Design outcomes

Primary

MeasureTime frameDescription
Change in peroxisome proliferator activated receptor (PPAR) gamma co-activator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA) expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercisePGC-1α gene expression (indirect indicator of PGC-1α activity). Transcriptional co-activator involved in the control of mitochondrial biogenesis.

Secondary

MeasureTime frameDescription
Change in nuclear factor-erythroid 2 like 2 (Nrf2) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseNrf2 gene expression (indirect indicator of Nrf2 activity). Transcription factor involved in the control of mitochondrial biogenesis.
Change in Nrf2 protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseNrf2 protein content
Change in PPAR-beta mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercisePPAR-beta gene expression (indirect indicator of PPAR-beta activity). Transcription factor involved in the control of mitochondrial biogenesis.
Change in estrogen related receptor (ERR)-gamma mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseERR-gamma gene expression. Transcription factor involved in the control of mitochondrial biogenesis.
Change in leucine-rich pentatricopeptide repeat containing protein 130 (LRP130) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseLRP130 gene expression. Transcriptional co-activator and RNA-binding protein involved in the transcriptional control and stabilization of mitochondrial mRNAs
Change in LRP130 protein contentbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseLRP130 protein content
Change in nuclear respiratory factor-1 (NRF-1) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseNRF-1 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.
Change in NRF-1 protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseNRF-1 protein content
Change in mitochondrial transcription factor A (TFAM) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseTFAM gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.
Change in TFAM protein contentbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseTFAM protein content
Change in PGC-1α protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exercisePGC-1α protein content
Change in cytochrome c oxidase subunit 4 (COXIV) mRNA expression.before exercise to 1, 3, 6, 9, and 12 hours post-exerciseCOXIV gene expression. Nuclear encoded subunit of the electron transport chain complex 4 (COX)
Change in COXI mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseCOXI gene expression. Mitochondrial encoded subunit of the electron transport chain complex IV (COX)
Change in COXII mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseCOXII gene expression.Mitochondrial encoded subunit of the electron transport chain complex IV (COX).
Change in nicotinamide adenine dinucleotide (NADH) subunit 1 (ND1) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseND1 gene expression. Mitochondrial encoded subunit of the electron transport chain complex 1 (NADH dehydrogenase)
Change in ND4 mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseND4 gene expression. Mitochondrial encoded subunit of the electron transport chain complex 1 (NADH dehydrogenase).
Change in citrate synthase (CS) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseCS gene expression. The first rate limiting enzyme of the Kreb's cycle.
Change in NRF-2 mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseNRF-2 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.
Change in mitochondrial transcription factor B1 (TFB1M) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exerciseTFB1M gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.
Change in mitochondrial transcription factor B2 (TFB2M) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exerciseTFB2M gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.
Change in p53 mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercisep53 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.

Countries

Canada

Contacts

Primary ContactHashim Islam, MSc
16mhi@queensu.ca4037954125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026